PEDIATRICS Vol. 57 No. 6 June 1976, pp. 935-941
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whelan, D. T.
Right arrow Articles by Spate, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whelan, D. T.
Right arrow Articles by Spate, M.

Citrullinemia: Phenotypic Variations

Donald T. Whelan M.D.1, Terry Brusso B.H.Sc., R.P.Dt.1, and Marilyn Spate B.A.1

1 Departments of Pediatrics, Pathology, and Nutritional Services, McMaster University Medical Centre, Hamilton, Ontario, Canada

An 18-month-old female infant was found to have citrullinemia on routine plasma screening by the Seriver Method at 5 days of age. At 10 days of age, plasma citrulline concentration was 0.704µmol/ml (normal, 0.010 to 0.030µmol/ml) and has remained 60 to 80 times higher than normal. Urine citrulline concentration was markedly elevated. Hyperammonemia occurred at 1 month of age. The serum ammonia concentration was 473µg/100 ml (normal, 50 to 250µg/100 ml) and rose to 770µg/100 ml at 4 months of age. Dietary protein was restricted to 1.6 gm/kg/day. Without further change in protein intake, the serum ammonia concentration decreased to 280µg/100 ml and, since then, it has returned to normal. The addition of three synthetic L-amino acids was required for a short time during dietary therapy. At 10 months of age, the infant was given a normal diet. At 18 months of age, her physical and mental development is normal. Activity of argininosuccinic acid synthetase measured in skin fibroblasts was 0.0037µmol of radioactive carbon dioxide per milligram of protein per hour. To demonstrate heterozygosity, fasting plasma citrulline concentrations were measured in five members of the family.

Comparison of findings in this patient with those reported in the literature suggests phenotypical variation of the disease, probably due to genetic heterogeneity.

Submitted on August 12, 1975
Accepted on October 3, 1975